Biden Admin Invests $24 Million in mRNA Technology to Treat Cancer, Other Diseases

Biden Admin Invests $24 Million in mRNA Technology to Treat Cancer, Other Diseases
President Joe Biden delivers a speech to mark the one-year anniversary of his signing into law the Promise to Address Comprehensive Toxics (PACT) Act at the George E. Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, Utah, on Aug. 10, 2023. Madalina Vasiliu/The Epoch Times
Katabella Roberts
Updated:
0:00

The Biden administration is investing up to $24 million to develop messenger RNA-based (mRNA) platforms and technology aimed at more effectively fighting cancer and other diseases.

The administration’s new biomedical research agency, the Advanced Research Projects Agency for Health (ARPA-H), is providing the $24 million investment in the “Curing the Uncurable via RNA-Encoded Immunogene Tuning” (CUREIT) project, according to an Aug. 23 statement from the White House.

Katabella Roberts
Katabella Roberts
Author
Katabella Roberts is a news writer for The Epoch Times, focusing primarily on the United States, world, and business news.
Related Topics